ArticleEuropean journal of clinical pharmacology2020

Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status.

Marit Tveito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.